ContraFect Corp (CFRX) Earns Daily Coverage Optimism Score of 0.22

Media stories about ContraFect Corp (NASDAQ:CFRX) have trended somewhat positive on Thursday, according to AlphaOne Sentiment Analysis. The research firm, a division of Accern, ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources. AlphaOne ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. ContraFect Corp earned a news impact score of 0.22 on AlphaOne’s scale. AlphaOne also assigned news articles about the biotechnology company an impact score of 12 out of 100, indicating that recent news coverage is very unlikely to have an effect on the company’s share price in the near future.

Separately, Maxim Group reiterated a “hold” rating on shares of ContraFect Corp in a research report on Wednesday.

ContraFect Corp (NASDAQ:CFRX) traded down 2.86% on Thursday, hitting $1.70. 23,714 shares of the company traded hands. ContraFect Corp has a 1-year low of $1.35 and a 1-year high of $4.12. The firm’s market capitalization is $70.82 million. The firm’s 50 day moving average price is $1.98 and its 200 day moving average price is $2.06.

ContraFect Corp (NASDAQ:CFRX) last released its quarterly earnings data on Wednesday, March 15th. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.20) by $0.21. Equities research analysts predict that ContraFect Corp will post ($0.73) EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by WKRB News and is owned by of WKRB News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at

5 Day Chart for NASDAQ:CFRX

This story was originally published by WKRB News ( and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at

Receive News & Ratings for ContraFect Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corp and related companies with's FREE daily email newsletter.


Leave a Reply

© 2006-2017 WKRB News.